LABESSE; Gilles

Patent Applications and Registrations

Patent applications and USPTO patent grants for LABESSE; Gilles.The latest application filed is for "azaindole derivatives and their use as erk kinase inhibitors".

Company Profile

3.5.11

LABESSE; Gilles - Montpellier FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Azaindole Derivatives And Their Use As Erk Kinase Inhibitors App 20210221809 - GUICHOU; Jean-Francois ; et al.	2021-07-22
Zaindole derivatives and their use as ERK kinase inhibitors Grant 10,995,089 - Guichou , et al. May 4, 2	2021-05-04
Zaindole Derivatives And Their Use As Erk Kinase Inhibitors App 20200283432 - GUICHOU; Jean-Francois ; et al.	2020-09-10
New Compounds For The Treatment And/or Prevention Of Parasitic Diseases And Method Of Production Of Thereof App 20190040004 - SERENO; Denis ; et al.	2019-02-07
N-hydroxybenzamides as HDAC inhibitors for the treatment of parasitic diseases Grant 10,106,493 - Sereno , et al. October 23, 2	2018-10-23
Phosphodeoxyribosyl transferase mutant enzymes and uses thereof Grant 9,523,084 - Kaminski , et al. December 20, 2	2016-12-20
New Compounds For The Treatment And/or Prevention Of Parasitic Diseases And Method Of Production Of Thereof App 20160168084 - SERENO; Denis ; et al.	2016-06-16
Phosphodeoxyribosyl Transferase Mutant Enzymes and Uses Thereof App 20150267181 - Kaminski; Pierre-Alexandre ; et al.	2015-09-24
Antibacterial compounds Grant 8,927,520 - Pochet , et al. January 6, 2	2015-01-06
Novel Antibacterial Compounds App 20130331351 - Pochet; Sylvie ; et al.	2013-12-12
Use Of The Protien Maba (fabg1) Of Mycobacterium Tuberculosis For Designing And Screening Antibiotics App 20100240084 - QUEMARD; Annaik ; et al.	2010-09-23
Complexes Of Nadp With The Protein Maba Of Mycobacterium Tuberculosis Or With Mutants Thereof, And Their Uses For Designing And Screening Antibiotics App 20100113291 - Labesse; Gilles ; et al.	2010-05-06
Aryl, Pyrimidyl Compounds, Pharmaceutical Compositions Comprising them, Their Use as Antimicrobial Agents App 20080096907 - Munier-Lehmann; Helene ; et al.	2008-04-24
Use of the protein maba (fabg1) of mycobacterium tuberculosis for designing and screening antibiotics App 20060035294 - Quemard; Annaik ; et al.	2006-02-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.